|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 07/16/2004
|
| 07/16/2004
|
| Private Industry
|
| Unilever United States
Inc
|
|
|
|
|
|
|
| pdf,
AppendixA
AppendixB
AppendixC
AppendixE
|
|
|
|
|
| Signature:
|
| Daniel R Dwyer
|
|
|
|
|
| ACK1
|
| 07/16/2004
|
| 07/16/2004
|
| Federal
Government
|
| HFS-800 to Unilever
United States Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Shellee Anderson
|
|
|
|
|
|
|
|
| MM1
|
| 07/16/2004
|
| 07/16/2004
|
| Federal
Government
|
| Between FDA and Unilever
United States Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Kathy Ellwood, Felicia
Satchell, Shelle
|
|
|
|
|
|
|
|
| SUP1
|
| 07/16/2004
|
| 07/16/2004
|
| Private Industry
|
| Unilever United States
Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Nancy L Schnell
|
|
|
|
|
| SUP2
|
| 07/16/2004
|
| 07/16/2004
|
| Private Industry
|
| Unilever United States
Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Nancy L Schnell
|
|
|
| SUP3
|
| 12/06/2004
|
| 12/01/2004
|
| Private Industry
|
| Unilever United States
Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Nancy L. Schnell
|
|
|
|
|
| LET1
|
| 11/29/2004
|
| 11/29/2004
|
| Private Industry
|
| Unilever United States
Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Nancy L Schnell
| |
|
| LET2
|
| 02/09/2005
|
| 02/09/2005
|
| Private Industry
|
| Unilever United States
Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Nancy L. Schnell
| |
